North East and North Cumbria
ICS Formulary
 
back
8 Malignant disease and immunosuppression
08-03-04-02 Prostate cancer and gonadorelin analogues

Radium-223 dichloride
Formulary
  • Provided by radiotherapy department in accordance with NICE
Link  NICE TA412: Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases
Link  MHRA Drug Safety Update (December 2017): Radium-223 dichloride (Xofigo▼): do not use in combination with abiraterone and prednisone/prednisolone, following clinical trial signal of increased risk of death and fractures  

Red View adult BNF  View SPC online  View childrens BNF  HCD
Relugolix Orgovyx®
Formulary
  • 120 mg film-coated tablets
  • Approved for treating prostate cancer in adults:

    • with advanced hormone-sensitive prostate cancer
    • alongside radiotherapy for high-risk localised or locally advanced hormone-sensitive prostate cancer
    • as neoadjuvant treatment before radiotherapy for high-risk localised or locally advanced hormone-sensitive prostate cancer in line with NICE
Link  NICE TA995 : Relugolix for treating hormone-sensitive prostate cancer

Green plus View adult BNF  View SPC online  View childrens BNF